专利号:US-2022160788-A1 优先权日:2019-03-22 标题 :Bifunctional vectors allowing bcl11a silencing and expression of an anti-sickling hbb and uses thereof for gene therapy of b-hemoglobinopathies 发明人:MICCIO ANNARITA; AMENDOLA MARIO; BRUSSON MÉGANE; CAVAZZANA MARINA; MAVILIO FULVIO 权利人:INST NAT SANTE RECH MED; UNIV DEVRY VAL DESSONNE; ASSIST PUBLIQUE HOPITAUX PARIS APHP; UNIV PARIS; FOND IMAGINE 摘要:The #β-hemoglobinopathies #β-thalassemia (BT) and sickle cell disease (SCD) are the most frequent genetic disorders worldwide. These diseases are caused by mutations causing reduced or abnormal synthesis of the β-globin chain of the adult hemoglobin (Hb) tetramer. Here, the inventors intend to improve HSC-based gene therapy for β-thalassemia and SCD by developing an innovative, highly infectious LV vector expressing a potent anti-sickling β-globin transgene and a second biological function either increasing fetal γ-globin expression (for β-thalassemia and SCD). More particularly, the inventors have designed a novel lentivirus (LV), which carry two different functions: βAS3 gene addition and gene silencing. This last strategy allows the re-expression of the fetal γ-globin genes (HBG1 and HBG2) and production of the endogenous fetal hemoglobin (HbF). Elevated levels of HbF and HbAS3 (Hb tetramer containing βAS3-globin) will benefit the β-hemoglobinopathy phenotype by increasing the total amount of β-like globin that will: (i) reduce the alpha precipitates and improve the alpha/non alpha ratio in β-thalassemia, and (ii) reduce the sickling in SCD. This combined strategy will improve the β-hemoglobinopathy phenotype at a lower vector copy number (VCN) per cell compared to a LV expressing the βAS3 alone.
专利号:US-6409988-B1 优先权日:1999-07-01 标 题:Radiolabeled 1-aryl pyrazoles, the synthesis thereof and the use thereof as pest GABA receptor ligands 发明人:DHANOA DALJIT S; MEEGALLA SANATH; DOLLER DARIO; SOLL RICHARD M 权利人:DIMENSIONAL PHARM INC 摘要:The present invention is directed to radiolabeled compounds of Formula I:or salts thereof, whereR1 represents R8, R8O, R8SO2, R8SO or R8S in which R8 is tritiated or deuterated methyl;X is halo, cyano, C1-6 alkoxycarbonyl, C2-6 alkynyl, optionally substitutedC6-14 aryl or an optionally substituted 5- to 7-membered heteroaromatic ring linked to thiazole via a carbon-carbon bond;R2 is hydrogen or amino; andR3-R7 are defined in the specification.The invention is also directed to methods of using such compounds for demonstrating specific insect GABA receptors, qualitatively screening for compounds acting on an insect GABA receptor or quantitatively assaying concentrations of a compound acting on an insect GABA receptor.
专利号:US-2006287397-A1 优先权日:2002-04-26 标 题:Dl-hydroxy-alkyl-phenylamides having anticonvulsive activity 发明人:MEZA TOLEDO SERGIO E 权利人:MEZA TOLEDO SERGIO E 摘要:New anticonvulsant compounds were synthesized and they include the compounds: DL-2-hydroxy-2-(3′,5′-bistrifluoromethylphenyl)butyramide, DL-2-hydroxy-2-(4′-trifluoromethylphenyl)butyramide, DL-2-hydroxy-2-(3′,4′-dichlorophenyl)butyramide, DL-2-hydroxy-2-(3′-bromophenyl)butyramide, DL-2-hydroxy-2-(4′-bromophenyl)butyramide, DL-2-hydroxy-2-(3′-nitrophenyl)butyramide, DL-3-hydroxy-3-(3′,4′-dichlorophenyl)pentanamide, DL-3-hydroxy-3-(4′-bromophenyl)pentanamide, DL-4-hydroxy-4-(3′,4′-dichlorophenyl) hexanamide and DL-4-hydroxy-4-(4′-bromophenyl)hexanamide. They have a significant anticonvulsant activity against pentylenetetrazol-induced seizures as well as unexpected differences in anticonvulsant activity respect those of the non-halogenated compounds. The invention further provides methods for the synthesis of the DL-hydroxy-alkyl-phenyl amides as exemplified in the examples.
专利号:WO-0040532-A2 优先权日:1998-12-31 标 题:Synthesis of dihydrohonokiol compositions
专利号:US-6518266-B1 优先权日:1999-07-22 标题:1- Aryl-3-thioalkyl pyrazoles, the synthesis thereof and the use thereof as insecticides 发明人:DHANOA DALJIT S; DOLLER DARIO; MEEGALLA SANATH; SOLL RICHARD M; WISNEWSKI NANCY; SILVER GARY; STINCHCOMB DAN T; SEWARD R LEE; AGRAFIOTIS DIMITRIS; SHA DEYOU 权利人:DIMENSIONAL PHARMACEUTICALS 3; HESKA CORP 摘要:The present invention is directed to novel pyrazole derivatives and their use as pesticidal agents. The pyrazole derivatives have Formula I:or a salt thereof, whereR1 represents R5O, R5SO2, R5SO or R5S in which R5 is as defined herein;X is halo, cyano, C1-6 alkoxycarbonyl, C2-6 alkynyl, optionally substituted C6-14 aryl or an optionally substituted 5- to 7-membered heteroaromatic ring linked to thiazole via a carbon-carbon bond;R2 is hydrogen, amino, chloro, bromo, iodo, cyano, C1-6 alkoxy, C1-6 alkyl or C6-10 aryl; andR3-R7 each represent hydrogen, halogen, straight- or branched-chain C1-4 alkyl or C1-4 alkoxy, either of which is unsubstituted or substituted by one or more halogen atoms, straight- or branched-chain C1-4 alkylthio or C1-4 alkylsulphinyl, either of which is substituted by one or more halogen atoms, nitro, cyano, or straight- or branched-chain C1-4 alkylsulphonyl group which is unsubstituted or substituted by one or more halogen atoms.
专利号:US-6545033-B1 优先权日:1999-10-06 标 题:Fused 1-(2,6-dichloro-4-trifluoromethylphenyl)-pyrazoles, the synthesis thereof and the use thereof as pesticides 发明人:DHANOA DALJIT S; MEEGALLA SANATH; SOLL RICHARD M; DOLLER DARIO; SHA DEYOU; LIU RUIPING; SILVER GARY; LEE YU-KAI 权利人:DIMENSIONAL PHARM INC 摘要:The present invention is directed to novel pyrazole derivatives and their use as pesticidal agents. The pyrazole derivatives have Formula I:or a salt thereof, whereR1 is amino, hydrogen, alkyl, hydroxy, halo, alkoxy, alkylamino, dialkylamino, alkylthio, alkylsulfinyl, alkylsulfonyl, trifluoroalkylsulfinyl, trifluoroalkylsulfonyl, hydroxy, amino, trifluoromethyl, acetylamino, -OSO2R2, -OS(O)R2, -OC(O)R2, -OC(O)NHR2, or -NHC(O)NHR2 where R2 is C1-4 alkyl or optionally substituted aryl;X, Y and Z are each independently (CH)n, (CR3R4)n, S, S(O), or SO2, wherein n is 1-2, R3 and R4 are defined herein;Q is N or C-R6, wherein R6 is fluoro, chloro, bromo, or iodo;R5 is halo, C1-C6 alkyl, C1-C4 alkenyl, C1-C4 alkoxy, C1-C4 alkylamino, C1-C4 dialkylamino, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 trifluoroalkylsulfinyl, C1-C4 trifluoroalkylsulfonyl, hydroxy, amino, or trifluoromethyl; andwith the proviso that only one of X, Y and Z can be S, S(O) or SO2.
1: Ma J, Lin C, Wen C, Xiang Z, Yang X, Wang X. Determination of bicuculline in rat plasma by liquid chromatography mass spectrometry and its application in a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Mar 15;953-954:143-6. doi: 10.1016/j.jchromb.2014.02.006. Epub 2014 Feb 18. doi: 10.1016/j.brainres.2012.03.015. Epub 2012 Mar 13. doi: 10.1016/j.saa.2011.09.022. Epub 2011 Sep 16. doi: 10.1016/j.bbr.2014.05.032. Epub 2014 May 24. doi: 10.1038/npp.2014.223. Epub 2014 Aug 28. 7: Rysakova MP, Pavlova IV. [Behavior of high- and low-anxiety rats after modulation of GABAergic transmission in basolateral amygdala]. Ross Fiziol Zh Im I M Sechenova. 2014 Jun;100(6):736-49. Russian. doi: 10.1016/j.pbb.2015.09.010. Epub 2015 Sep 12. doi: 10.1016/j.bbr.2014.06.032. Epub 2014 Jun 21. Erratum in: J Physiol (Lond) 1995 Jun 15;485(Pt 3):873. 13: Karson AB, Aker R, Ateş N, Onat F. Cardiovascular effects of intracerebroventricular bicuculline in rats with absence seizures. Epilepsy Res. 1999 Apr;34(2-3):231-9. doi: 10.1007/s00702-014-1211-5. Epub 2014 Apr 20. doi: 10.1016/j.ejphar.2013.08.027. Epub 2013 Sep 11.
合成参考文献
参考文献:10.1159/000089934 摘要:Zarrindast MR, Noorbakhshnia M, Motamedi F, Haeri-Rohani A, Rezayof A. Effect of the GABAergic system on memory formation and state-dependent learning induced by morphine in rats. Pharmacology. 2006;76(2):93–100. doi: 10.1159/000089934. 参考文献:10.1016/j.neuroscience.2011.06.073 摘要:Castro A, Aguilar J, Andrés C, Felix R, Delgado-Lezama R. GABAA receptors mediate motoneuron tonic inhibition in the turtle spinal cord. Neuroscience. 2011 Sep 29;192():74–80. doi: 10.1016/j.neuroscience.2011.06.073. 参考文献:10.1155/2011/693426 摘要:Qian H, Ripps H. Neurovascular Interaction and the Pathophysiology of Diabetic Retinopathy. Experimental Diabetes Research. 2011;2011():1–11. doi: 10.1155/2011/693426. 参考文献:10.1152/ajpregu.00144.2011 摘要:Horiuchi J, Atik A, Iigaya K, McDowall LM, Killinger S, Dampney RAL. Activation of 5-hydroxytryptamine-1A receptors suppresses cardiovascular responses evoked from the paraventricular nucleus. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2011 Oct;301(4):R1088–97. doi: 10.1152/ajpregu.00144.2011. 参考文献:10.1155/2011/935631 摘要:Liu A, Björkman T, Stewart C, Nanan R. Pharmacological Treatment of Neonatal Opiate Withdrawal: Between the Devil and the Deep Blue Sea. International Journal of Pediatrics. 2011;2011():1–5. doi: 10.1155/2011/935631.